@lung_ine2021 @ThanksCancer @LeciaSequist @JackWestMD @StephenVLiu @EGFRResisters @DFEGFRcenter It is rare adverse event. Few publications by our group on this topic https://t.co/3ZQu3XXpqI https://t.co/DkOxqjJD1a
RT @ELS_Cardiology: Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS) https://t…
RT @ELS_Cardiology: Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS) https://t…
Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS) https://t.co/d741rBIc3t #SoMe #medtwitter #MedEd @JACCJournals https://t.co/JOaaQ03xoc
Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS) https://t.co/8mPDo5TeBE #SoMe #medtwitter #MedEd https://t.co/QAxA5KCivv
Osimertinib-Induced Cardiotoxicity | JACC: CardioOncology https://t.co/kyLKSqahCx
RT @OncoCard_Ganken: ■Memo #EGFR_TKI #Osimertinib #タグリッソ #CardiacFailure #AFib #longQT Osimertinib-Induced Cardiotoxicity https://t.co/iN…
■Memo #EGFR_TKI #Osimertinib #タグリッソ #CardiacFailure #AFib #longQT Osimertinib-Induced Cardiotoxicity https://t.co/iN80hI7IKQ #CardioOnc
RT @CampbellMDPhD: Higher rates of cardiac failure, AF, and QT prolongation with osimertinib vs other TKI's. @JACCJournals https://t.co/n7…
RT @CampbellMDPhD: Higher rates of cardiac failure, AF, and QT prolongation with osimertinib vs other TKI's. @JACCJournals https://t.co/n7…
RT @CampbellMDPhD: Higher rates of cardiac failure, AF, and QT prolongation with osimertinib vs other TKI's. @JACCJournals https://t.co/n7…
Higher rates of cardiac failure, AF, and QT prolongation with osimertinib vs other TKI's. @JACCJournals https://t.co/n7sXUYReRl #cardioonc #cardiotwitter https://t.co/1kcFjZCRaF
RT @JACCJournals: Analysis of a pharmacovigilance FDA database suggests #osimertinib use has an increased risk of #heartfailure, #AFib and…
RT @drbrowncares: 1/ Introducing my Tweetorial thread on Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Even…
RT @drbrowncares: 1/ Introducing my Tweetorial thread on Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Even…
RT @drbrowncares: 1/ Introducing my Tweetorial thread on Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Even…
RT @drbrowncares: 1/ Introducing my Tweetorial thread on Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Even…
RT @JACCJournals: Analysis of a pharmacovigilance FDA database suggests #osimertinib use has an increased risk of #heartfailure, #AFib and…
RT @JACCJournals: Analysis of a pharmacovigilance FDA database suggests #osimertinib use has an increased risk of #heartfailure, #AFib and…
RT @drbrowncares: 1/ Introducing my Tweetorial thread on Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Even…
RT @drbrowncares: 1/ Introducing my Tweetorial thread on Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Even…
RT @JACCJournals: Analysis of a pharmacovigilance FDA database suggests #osimertinib use has an increased risk of #heartfailure, #AFib and…
RT @drbrowncares: 1/ Introducing my Tweetorial thread on Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Even…
RT @JACCJournals: Analysis of a pharmacovigilance FDA database suggests #osimertinib use has an increased risk of #heartfailure, #AFib and…
RT @drbrowncares: 1/ Introducing my Tweetorial thread on Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Even…
RT @drbrowncares: 1/ Introducing my Tweetorial thread on Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Even…
RT @drbrowncares: 1/ Introducing my Tweetorial thread on Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Even…
RT @drbrowncares: 1/ Introducing my Tweetorial thread on Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Even…
RT @drbrowncares: 1/ Introducing my Tweetorial thread on Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Even…
1/ Introducing my Tweetorial thread on Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS) #CardioOnc #CardioOncology #Osimertinib
RT @JACCJournals: Analysis of a pharmacovigilance FDA database suggests #osimertinib use has an increased risk of #heartfailure, #AFib and…
RT @JACCJournals: Analysis of a pharmacovigilance FDA database suggests #osimertinib use has an increased risk of #heartfailure, #AFib and…
RT @EricBernicker: Happy about this but all the kudos should go to our former fellow Kartik Anand-- he deserves all the credit with this wo…
RT @EricBernicker: Happy about this but all the kudos should go to our former fellow Kartik Anand-- he deserves all the credit with this wo…
RT @JACCJournals: Analysis of a pharmacovigilance FDA database suggests #osimertinib use has an increased risk of #heartfailure, #AFib and…
Happy about this but all the kudos should go to our former fellow Kartik Anand-- he deserves all the credit with this work !
RT @JACCJournals: Analysis of a pharmacovigilance FDA database suggests #osimertinib use has an increased risk of #heartfailure, #AFib and…
RT @JACCJournals: Analysis of a pharmacovigilance FDA database suggests #osimertinib use has an increased risk of #heartfailure, #AFib and…
RT @JACCJournals: Analysis of a pharmacovigilance FDA database suggests #osimertinib use has an increased risk of #heartfailure, #AFib and…
RT @JACCJournals: Analysis of a pharmacovigilance FDA database suggests #osimertinib use has an increased risk of #heartfailure, #AFib and…
RT @JACCJournals: Analysis of a pharmacovigilance FDA database suggests #osimertinib use has an increased risk of #heartfailure, #AFib and…
RT @JACCJournals: Analysis of a pharmacovigilance FDA database suggests #osimertinib use has an increased risk of #heartfailure, #AFib and…
Analysis of a pharmacovigilance FDA database suggests #osimertinib use has an increased risk of #heartfailure, #AFib and QT prolongation. Drs. @bhtrachtenberg, @EricBernicker and colleagues from @HMethodistCV discuss osimertinib toxicity in #JACCCardioOnc.
New study in #JACC on comparing risk of #cardiotoxicity with osimertinib versus all other drugs, finding the RORs for cardiac failure, AF, and QT prolongation were higher due to osimertinib compared with other TKIs. @KAnandMD @bhtrachtenberg @EricBernicker
RT @KAnandMD: Osimertinib induced cardiotoxicity https://t.co/sUzd5cQjpt @bhtrachtenberg @EricBernicker
RT @KAnandMD: Osimertinib induced cardiotoxicity https://t.co/sUzd5cQjpt @bhtrachtenberg @EricBernicker
RT @bhtrachtenberg: Great study led by @KAnandMD on cardiac adverse events of osimertinib @JACCJournals #cardioOnc https://t.co/NUxLtJPg06…
Excellent work by our former fellow Kartik Anand! #cardiotoxicity # LCSM
RT @bhtrachtenberg: Great study led by @KAnandMD on cardiac adverse events of osimertinib @JACCJournals #cardioOnc https://t.co/NUxLtJPg06…
Great study led by @KAnandMD on cardiac adverse events of osimertinib @JACCJournals #cardioOnc https://t.co/NUxLtJPg06 @MethodistHosp @HMethodistCV @EricBernicker
RT @KAnandMD: Osimertinib induced cardiotoxicity https://t.co/sUzd5cQjpt @bhtrachtenberg @EricBernicker
Osimertinib induced cardiotoxicity https://t.co/sUzd5cQjpt @bhtrachtenberg @EricBernicker